| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 135,200 | $1 | $540.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,950 | $30 | $406.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 8,470 | $20 | $203.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,170 | $10 | $188.9K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 20,790 | $10 | $166.3K |
| J0897 | Injection, denosumab, 1 mg | 6,360 | $20 | $114.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,160 | $70 | $77.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 560 | $60 | $33K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 2,230 | $10 | $24.5K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 1,290 | $20 | $23.2K |